Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome
Clinical trial NCT02758626 · COMPLETED
Trial details
- NCT number
- NCT02758626
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2021-02-27
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.